Friday, July 10, 2026

Drug profile · INN

nemonoxacin

nemonoxacin is a bacterial dna gyrase inhibitor.

NMPA: clinical trials
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — nemonoxacin
Class
Route
Patents
0
Programs
2
Data quality
0.70

Quick answer

nemonoxacin is a bacterial dna gyrase inhibitor.

Key facts

INN nemonoxacin
Mechanism Bacterial DNA gyrase inhibitor
Target Bacterial DNA gyrase

Mechanism of action

Bacterial DNA gyrase inhibitor

Primary target: Bacterial DNA gyrase

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. TG-873870 (Nemonoxacin) Phase 2 · BioMarin Pharmaceutical · Diabetic Foot Infections
  2. Nemonoxacin Phase 1 · LianBio · Kidney Dysfunction

Related & competitor drugs

  1. cinoxacin Bacterial DNA gyrase inhibitor
  2. ciprofloxacin Bacterial DNA gyrase inhibitor
  3. ciprofloxacin hydrochloride Bacterial DNA gyrase inhibitor
  4. moxifloxacin hydrochloride Bacterial DNA gyrase inhibitor
  5. ofloxacin Bacterial DNA gyrase inhibitor
  6. alatrofloxacin mesylate Bacterial DNA gyrase inhibitor

Frequently asked questions

What is nemonoxacin?

nemonoxacin is a bacterial dna gyrase inhibitor.